Clinical Trial Update: Lenalidomide With or Without Rituximab in Treating Patients With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma Who Have Undergone Autologous or Syngeneic Stem Cell Transplant [Phase 2]

View source ↗

Summary

Phase 2 trial of lenalidomide with or without rituximab in patients with chronic lymphocytic leukemia or small lymphocytic lymphoma after autologous or syngenei…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Lymphocytic Leukemia
• Small Lymphocytic Lymphoma

Drugs mentioned

• Lenalidomide (lenalidomide)
• Rituximab (rituximab)

Snippet

Sponsor: Fred Hutchinson Cancer Center | Conditions: Leukemia, Lymphoma | Phase 2 | Status: WITHDRAWN